Psoriasis is a frequent immune-mediated disease with either skin or joint manifestations, or
both, which has a major impact on quality of life. Although there is currently no cure for …

Background Psoriasis is an immune‐mediated disease with either skin or joints
manifestations, or both, and it has a major impact on quality of life. Although there is …

Importance The clinical benefits of novel treatments for moderate to severe psoriasis are
well established, but wide variations exist in patient response across different therapies. In …

Background Psoriasis is an immune-mediated chronic inflammatory disease that affects the
skin and/or joints of a person. Although the exact cause of psoriasis has not been …

Network meta-analyses of systemic treatments for psoriasis: a critical appraisal: Original
Articles: Jabbar-Lopez ZK, Yiu ZZN, Ward V et al. Quantitative evaluation of biologic therapy …

Objectives To assess the comparability of the trials included in network meta-analyses
(NMAs) comparing biologic treatments in moderate to severe plaque psoriasis (PsO) …

The number of available systemic treatments for psoriasis, including biologics, has
increased rapidly in recent years, necessitating up-to-date and comprehensive comparative …

Numerous network meta-analyses have provided comparative efficacy and safety data for
treatments in psoriaasis over a short period (8-24 weeks). So, we conducted a systematic …

Introduction Le nombre de traitements systémiques (TS) disponibles dans l'indication
psoriasis modéré à sévère a augmenté de façon considérable durant les 20 dernières …

Background: A comprehensive assessment of the risk-benefit profile of biologic agents in
psoriasis is lacking. We conducted a network meta-analysis of randomized trials on biologic …